Recombinant activated factor VII in cardiac surgery

Adult cardiac surgery has an incidence of 1–1.25 million procedures per year. Overall costs are in the range of US$50 billion per year and are increasing. Included in these costs is an increasing burden from the use of blood and blood products. The central haemostatic problems associated with cardia...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood coagulation & fibrinolysis 2004-05, Vol.15 Suppl 1 (Supplement 1), p.S31-S32
1. Verfasser:	Herbertson, Mike
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Blood Loss, Surgical - prevention & control Cardiac Surgical Procedures Clinical Trials as Topic Factor VII - pharmacokinetics Factor VIIa Hemostasis - drug effects Humans Perioperative Care Recombinant Proteins - pharmacokinetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!